MedTrace Logo

Dexamethasone With Super-hydration for Prevention of Postoperative Nausea and Vomiting

NCT02726308 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-04-01

No results posted yet for this study

Summary

Postoperative nausea and vomiting (PONV) are the most common and distressing side effects following Laparoscopic cholecystectomy

Conditions

  • Nausea and Vomiting, Postoperative

Interventions

DRUG

Dexamethasone

5 mg I.V. Dexamethasone just before induction

DRUG

10 ml/kg Ringer's lactate

Intra-operative 10 ml/kg Ringer's lactate solution .

DRUG

30 ml/kg Ringer's lactate

Intra-operative 30 ml/kg Ringer's lactate solution .

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • sayed abd elshafy, MD · associate professor of anesthesia and critical care

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726308 on ClinicalTrials.gov